Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 14/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | IARS1 | P41252 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7779224 | 1.00 | DPP4 (0.43) | DPP4DPP8DPP9DPP7TSHR | |
| SCHEMBL21105595 | 1.00 | DPP4 (0.43) | DPP4DPP8DPP9DPP7TSHR | |
| Hydrochloric Acid SCHEMBL11122949 | 0.98 | DPP4 (0.42) | DPP4DPP8DPP9DPP7TSHR | |
| Hydrochloric Acid SCHEMBL16007456 | 0.98 | DPP4 (0.42) | DPP4DPP8DPP9DPP7TSHR | |
| SCHEMBL22890984 | 0.85 | DPP4 (0.42) | DPP4DPP8DPP9DPP7IARS1 | |
| SCHEMBL8751922 | 0.85 | DPP4 (0.42) | DPP4DPP8DPP9DPP7IARS1 | |
| SCHEMBL2783500 | 0.84 | DPP4 (0.47) | DPP4DPP8DPP9DPP7IARS1 | |
| SCHEMBL3930248 | 0.82 | DPP4 (0.46) | DPP4DPP8DPP9DPP7IARS1 | |
| SCHEMBL5161688 | 0.82 | DPP4 (0.46) | DPP4DPP8DPP9DPP7IARS1 | |
| SCHEMBL3730204 | 0.82 | DPP4 (0.43) | DPP4DPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3912984-A1 | 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV | Janssen BioPharma, Inc. (US) | 2021-11-24 | — | — | EP | claimed |
| EP-2935303-B1 | 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV | JANSSEN BIOPHARMA INC (US) | 2021-02-17 | — | — | EP | claimed |
| EP-3421482-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | Alios Biopharma, Inc. (US) | 2019-01-02 | — | — | EP | claimed |
| CN-107250146-A | Substituted nucleosides, nucleotides and the like | 艾丽奥斯生物制药有限公司 | 2017-10-13 | — | — | CN | claimed |
| WO-2016100441-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | ALIOS BIOPHARMA, INC. (US) | 2016-06-23 | — | — | WO | claimed |
| CN-105343097-A | Composition containing caffeine and application and manufacturing method of composition containing caffeine | TIANJIN JIANLAIDE TECHNOLOGY CO LTD | 2016-02-24 | — | — | CN | claimed |
| CN-105073766-A | Substituted nucleosides, nucleotides and analogs thereof | ALIOS BIOPHARMA INC (US) | 2015-11-18 | — | — | CN | claimed |
| EP-2935305-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | Alios Biopharma, Inc. (US) | 2015-10-28 | — | — | EP | claimed |
| EP-2935303-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | Alios Biopharma, Inc. (US) | 2015-10-28 | — | — | EP | claimed |
| EP-2794630-A1 | SUBSTITUTED PHOSPHOROTHIOATE NUCLEOTIDE ANALOGS | Alios Biopharma, Inc. (US) | 2014-10-29 | — | — | EP | claimed |
| WO-2014100498-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | ALIOS BIOPHARMA, INC. (US) | 2014-06-26 | — | — | WO | claimed |
| WO-2014100505-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | ALIOS BIOPHARMA, INC. (US) | 2014-06-26 | — | — | WO | claimed |
| WO-2013096680-A1 | SUBSTITUTED PHOSPHOROTHIOATE NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2013-06-27 | — | — | WO | claimed |
| WO-2025061048-A1 | STEROID COMPOUND AND USE THEREOF | 润尔眼科药物（广州）有限公司 | 2025-03-27 | — | — | WO | disclosed |
| EP-3912984-A1 | 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV | Janssen BioPharma, Inc. (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-3421482-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | Alios Biopharma, Inc. (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0403828-A1 | Renin-inhibiting peptides, their preparation and their use in medicaments | BAYER AG (DE) | 1990-12-27 | — | — | EP | disclosed |